Gayle Capozzalo - Universal Health Independent Trustee
UHT Stock | USD 39.58 0.11 0.28% |
Executive
Ms. Gayle L. Capozzalo an Independent Trustee of the company since March, 2018. Ms. Capozzalo formerly served as the Executive Vice President and Chief Strategy Officer of Yale New Haven Health since 1997. Prior thereto, she served as Senior Vice President, Organizational Development at Sisters of Charity of the Incarnate Word Health Care System. Ms. Capozzalo has more than 30 years of experience in strategy, organizational development, and management and has significantly grown, and integrated successful healthcare systems. She recently was appointed to the .406 Ventures Healthcare Executive Council, a VC firm specializing in early stage and de novo investments in emerging market segments in Fintech sector and is the Senior Strategy Advisor to PhysicianOne Urgent Care, a private equity company since 2018.
Age | 70 |
Tenure | 7 years |
Address | Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 |
Phone | 610 265 0688 |
Web | https://www.uhrit.com |
Universal Health Management Efficiency
The company has Return on Asset of 0.0387 % which means that on every $100 spent on assets, it made $0.0387 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0927 %, implying that it generated $0.0927 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Universal Health's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.10 in 2025, whereas Return On Tangible Assets are likely to drop 0.03 in 2025. At this time, Universal Health's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 461.8 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 14.2 M in 2025.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Michael Sotelo | CareTrust REIT | N/A | |
Lukas CFA | Sabra Healthcare REIT | N/A | |
Daniel JD | Healthpeak Properties | 59 | |
Tracy Porter | Healthpeak Properties | N/A | |
Antonio Acevedo | Healthpeak Properties | N/A | |
Ava Liasbooker | Healthpeak Properties | 60 | |
Andrew CFA | Healthpeak Properties | N/A | |
Michelle Kelly | National Health Investors | N/A | |
Thomas Klaritch | Healthpeak Properties | 67 | |
Amanda Callaway | Healthcare Realty Trust | 46 | |
Darrin Smith | Sabra Healthcare REIT | N/A | |
Beth Blankenship | National Health Investors | N/A | |
Adam Mabry | Healthpeak Properties | 39 | |
Lauren Beale | CareTrust REIT | N/A | |
Mark Baumgartner | Healthpeak Properties | 65 | |
Bradley JD | Healthpeak Properties | 63 | |
Kara Pappanduros | Sabra Healthcare REIT | N/A | |
James Callister | CareTrust REIT | 48 | |
William Ebinger | Healthpeak Properties | 66 | |
Alfonzo Leon | Global Medical REIT | 49 | |
Ronald Hubbard | Healthcare Realty Trust | N/A |
Management Performance
Return On Equity | 0.0927 | ||||
Return On Asset | 0.0387 |
Universal Health Realty Leadership Team
Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert McCadden, Lead Independent Trustee | ||
Cheryl Ramagano, Vice President, Treasurer, Secretary | ||
Gayle Capozzalo, Independent Trustee | ||
Judith Romero, Vice Management | ||
James Morey, Independent Director | ||
Charles Boyle, Chief Financial Officer, Vice President | ||
Judith Klein, Vice Management | ||
Alan Miller, Chairman of the Board of Trustee, President, Chief Executive Officer | ||
Genevieve Owsiany, VP Controller | ||
Marc Miller, Trustee | ||
Karla Peterson, Vice Development | ||
Timothy Fowler, Vice President - Acquisition and Development | ||
Michael Domb, Independent Trustee |
Universal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0927 | ||||
Return On Asset | 0.0387 | ||||
Profit Margin | 0.18 % | ||||
Operating Margin | 0.35 % | ||||
Current Valuation | 912.38 M | ||||
Shares Outstanding | 13.85 M | ||||
Shares Owned By Insiders | 8.21 % | ||||
Shares Owned By Institutions | 64.30 % | ||||
Number Of Shares Shorted | 247.58 K | ||||
Price To Earning | 34.86 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Universal Stock Analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.